학술논문
Influence of microbiota-associated metabolic reprogramming on clinical outcome in patients with melanoma from the randomized adjuvant dendritic cell-based MIND-DC trial.
Document Type
Article
Author
Alves Costa Silva, Carolina; Piccinno, Gianmarco; Suissa, Déborah; Bourgin, Mélanie; Schreibelt, Gerty; Durand, Sylvère; Birebent, Roxanne; Fidelle, Marine; Sow, Cissé; Aprahamian, Fanny; Manghi, Paolo; Punčochář, Michal; Asnicar, Francesco; Pinto, Federica; Armanini, Federica; Terrisse, Safae; Routy, Bertrand; Drubay, Damien; Eggermont, Alexander M. M.; Kroemer, Guido
Source
Nature Communications; 2/23/2024, Vol. 15 Issue 1, p1-16, 16p
Subject
Language
ISSN
20411723
Abstract
Copyright of Nature Communications is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)